glucagon has been researched along with Psychoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bocchio-Chiavetto, L; Bonetto, C; Bruschi, C; D'Agostino, A; Faravelli, C; Furlato, K; Gennarelli, M; Imbesi, M; Lasalvia, A; Minelli, A; Preti, A; Ruggeri, M; Scocco, P; Tomassi, S; Tosato, S; Zanardini, R | 1 |
| Bocchio-Chiavetto, L; Bonetto, C; De Girolamo, G; Favaro, A; Ferrari, C; Fioritti, A; Frisoni, GB; Gennarelli, M; Giubilini, F; Lasalvia, A; Pavanati, M; Pileggi, F; Pratelli, M; Ruggeri, M; Tosato, S; Ventriglia, M; Zanardini, R | 1 |
2 other study(ies) available for glucagon and Psychoses
| Article | Year |
|---|---|
Childhood trauma and glucose metabolism in patients with first-episode psychosis.
Topics: Adult; Adverse Childhood Experiences; Antipsychotic Agents; Biomarkers; C-Peptide; Female; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Resistance; Leptin; Male; Middle Aged; Nicotinamide Phosphoribosyltransferase; Plasminogen Activator Inhibitor 1; Psychotic Disorders; Resistin | 2020 |
Immune and metabolic alterations in first episode psychosis (FEP) patients.
Topics: Adult; Antipsychotic Agents; Biomarkers; Chemokine CCL4; Chemokines; Cytokines; Female; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Interleukin-17; Interleukin-6; Leptin; Male; Plasminogen Activator Inhibitor 1; Psychotic Disorders; Vascular Endothelial Growth Factor A; Young Adult | 2018 |